Clopidogrel 150 Mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention. Results from the Vasp-02 Randomized Study

被引：0
|
作者：
Aleil, Boris [1 ]
Jacquemin, Laurent [2 ]
De Poli, Fabien [3 ]
Zaehringer, Michel [1 ]
Collet, Jean-Philippe [4 ]
Montalescot, Gilles [4 ]
Cazenave, Jean-Pierre [5 ]
Dickele, Marie-Claude [3 ]
Monassier, Jean-Pierre [2 ]
Gachet, Christian [5 ]
机构：
[1] Clin Orangerie, Strasbourg, France
[2] Hop Emile Muller, Mulhouse, France
[3] Ctr Hosp Gen, Haguenau, France
[4] Hop La Pitie Salpetriere, Paris, France
[5] EFS Alsace, INSERM, U311, Strasbourg, France
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S820 / S820
页数：1
相关论文
共 50 条
  • [41] Long-term Clopidogrel Therapy at the Loading Dose of 150 mg Daily Can Decrease Rate of Recurrent Cardiovascular Ischemic Events for Patients Undergoing Percutaneous Coronary Intervention
    Lin, L. J.
    Tang, F. K.
    Hua, N.
    Tang, X. Z.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S323 - S323
  • [42] Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study
    Yang, Yujin
    Park, Gyung-Min
    Han, Seungbong
    Kim, Yong-Giun
    Suh, Jon
    Park, Hyun Woo
    Won, Ki-Bum
    Ann, Soe Hee
    Kim, Shin-Jae
    Kim, Dae-Won
    Park, Mahn-Won
    Hee, Sung Ho
    Lee, Sang-Gon
    PLOS ONE, 2018, 13 (12):
  • [43] High clopidogrel loading dose is superior to a standard 300 mg regimen in patients undergoing percutaneous coronary intervention: evidence from a meta-analysis
    Biondi-Zoccai, G.
    Moretti, C.
    Agostoni, P.
    Valgimigli, M.
    Abbate, A.
    Angiolillo, D.
    Montalescot, G.
    Sangiorgi, G.
    Trevi, G.
    Sheiban, I.
    EUROPEAN HEART JOURNAL, 2007, 28 : 215 - 215
  • [44] Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention
    Kimura, Takeshi
    Isshiki, Takaaki
    Ogawa, Hisao
    Yokoi, Hiroyoshi
    Yamaguchi, Tetsu
    Ikeda, Yasuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2015, 22 (06) : 557 - 569
  • [45] Increased Mortality Associated With Low Use of Clopidogrel in Patients With Heart Failure and Acute Myocardial Infarction Not Undergoing Percutaneous Coronary Intervention A Nationwide Study
    Bonde, Lisbeth
    Sorensen, Rikke
    Fosbol, Emil Loldrup
    Abildstrom, Steen Zabell
    Hansen, Peter Riis
    Kober, Lars
    Schramm, Tina Ken
    Bretler, Ditte-Marie
    Weeke, Peter
    Olesen, Jonas
    Torp-Pedersen, Christian
    Gislason, Gunnar Hilmar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (13) : 1300 - 1307
  • [46] DE-ESCALATION FROM PRASUGREL OR TICAGRELOR TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Shehata, Joseph
    Abdelazeem, Basel
    Abbas, Kirellos Said
    El-Shahat, Nahla Ahmed
    Baral, Nischit
    Adhikari, Govinda
    Khan, Hafiz
    Hassan, Mustafa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 3471 - 3471
  • [47] Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial†
    Di Sciascio, Germano
    Patti, Giuseppe
    Pasceri, Vincenzo
    Colonna, Giuseppe
    Mangiacapra, Fabio
    Montinaro, Antonio
    EUROPEAN HEART JOURNAL, 2010, 31 (11) : 1337 - 1343
  • [48] Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
    Lewis, BS
    Mehta, SR
    Fox, KAA
    Halon, DA
    Zhao, F
    Peters, RJG
    Keltai, M
    Budaj, A
    Yusuf, S
    AMERICAN HEART JOURNAL, 2005, 150 (06) : 1177 - 1184
  • [49] Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial
    Montalescot, Gilles
    Gallo, Richard
    White, Harvey D.
    Cohen, Marc
    Steg, Gabriel
    Aylward, Philip E. G.
    Bode, Christoph
    Chiariello, Massimo
    King, Spencer B., III
    Harrington, Robert A.
    Desmet, Walter J.
    Macaya, Carlos
    Steinhubl, Steven R.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (11) : 1083 - 1091
  • [50] Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention - Results of the elective PCI in outpatient study (EPOS)
    Heyde, Gerlind S.
    Koch, Karel T.
    de Winter, Robbert J.
    Dijkgraaf, Marcel G. W.
    Klees, Margriet I.
    Dijksman, Lea M.
    Piek, Jan J.
    Tijssen, Jan G. P.
    CIRCULATION, 2007, 115 (17) : 2299 - 2306
12345